Arformoterol

Arformoterol is a long-acting beta-agonist used for the management of chronic obstructive pulmonary disease (COPD). It helps in relaxing the muscles in the airways, making it easier to breathe.

Indications

-Chronic Obstructive Pulmonary Disease (COPD) -May be used in combination with other medications for enhanced efficacy in managing COPD symptoms.

Dosage

-Typically administered via inhalation, using a nebulizer. -Standard dosage: 15 mcg twice daily. -Dosage adjustments may be required based on patient response and tolerance.

Contra-Indications

-Hypersensitivity to Arformoterol or any component of the formulation. -Should not be used as a rescue medication for acute bronchospasm. -Caution in patients with cardiovascular disorders, such as hypertension or arrhythmias.

Special Precautions

-Monitor patients for signs of paradoxical bronchospasm. -Use with caution in patients with diabetes, as beta-agonists may increase blood glucose levels. -Regularly assess lung function to ensure the medication is effective.

Side Effects

-Common: Tremors, headache, dizziness, dry mouth. -Less common: Palpitations, tachycardia, hypertension, rash.

Drug Interactions

-May interact with other beta-agonists, leading to an increased risk of cardiovascular side effects. -Caution when used with monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants (TCAs) due to potential for enhanced effects. -Potential interaction with medications affecting potassium levels, such as diuretics.